Trial Profile
To compare efficacy and safety of Telaprevir combined with pegylated interferon and ribavirin with reduced dose of Telaprevir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2017 New trial record